Skip to main content
Baxdrostat (CIN-107) CAS#: 1428652-17-8
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameBaxdrostat (CIN-107)IUPAC NameN-propanamideMolecular StructureCAS Registry Number 1428652-17-8SynonymsBaxdrostatBaxdrostat NF3P9Z8J5Y1428652-17-8UNII-NF3P9Z8J5Y(+)-(R)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamideN-((8R)-5,6,7,8-Tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)propanamidePropanamide, N-((8R)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)-CIN107CHEMBL4113975SCHEMBL14799753GTPL12362CIN-107BDBM233806GLXC-26998MS-25786HY-132809RO6836191CS-0204056G18370US9353081, 3-1N-propanamideMolecular Formula C22H25N3O2Molecular Weight363.5InChIInChI=1S/C22H25N3O2/c1-3-21(26)24-19-6-4-5-16-17(12-23-13-18(16)19)14-7-9-20-15(11-14)8-10-22(27)25(20)2/h7,9,11-13,19H,3-6,8,10H2,1-2H3,(H,24,26)/t19-/m1/s1InChI KeyVDEUDSRUMNAXJG-LJQANCHMSA-NIsomeric SMILESCCC(=O)N1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C

Patent InformationPatent IDTitlePublication DateUS2013/79365NEW BICYCLIC DIHYDROQUINOLINE-2-ONE DERIVATIVES2013WO2013/41591NEW BICYCLIC DIHYDROQUINOLINE-2-ONE DERIVATIVES2013

Physical Data

AppearanceSolid

Spectra

No data available

Route of Synthesis (ROS)

Route of Synthesis (ROS) of Baxdrostat (CIN-107) CAS 1428652-17-8

ConditionsYieldWith Chiralpak AD In n-heptane; isopropyl alcohol Resolution of racemate;Experimental Procedure2; 3 (-)-(R or S)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide and (+)-(S or R)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide(-)-(R or S)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide and (+)-(S or R)-N-(4-(1-Methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamideThe title compounds were prepared by chiral separation of (rac)-N-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide (example 1) on a Chiralpak AD (40% 2-propanol in n-heptane) to give after precipitation from CH2Cl2 with n-pentane 28% of (-)-(R or S)-N-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide (example 2) as off-white powder, MS: 364.2 (M+H+) and 26% of (+)-(S or R)-N-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide (example 3) as off-white powder. MS: 364.2 (M+H+).A 28%B 26%

Safety and Hazards

Pictogram(s)SignalWarningGHS Hazard StatementsH302 (100%): Harmful if swallowed H361d (100%): Suspected of damaging the unborn child H373 (100%): May causes damage to organs through prolonged or repeated exposure Precautionary Statement CodesP203, P260, P264, P270, P280, P301+P317, P318, P319, P330, P405, and P501(The corresponding statement to each P-code can be found at the GHS Classification page.)

Other Data

HS CodeStorageUnder room temperature away from lightShelf Life2 yearsMarket Price

DruglikenessLipinski rules componentMolecular Weight363.459logP2.309HBA5HBD1Matching Lipinski Rules4Veber rules componentPolar Surface Area (PSA)62.3Rotatable Bond (RotB)4Matching Veber Rules2

Use PatternBaxdrostat (CIN-107) is an aldosterone synthase inhibitor (ASI) intended for antihypertensive treatment in refractory hypertension. It directly inhibits the synthesis of aldosterone, contributing to its blood pressure-lowering effects.
https://www.chemwhat.com/baxdrostat-cin-107-cas-1428652-17-8/

Comments

Post a Comment

Popular posts from this blog

Watson's PDHP CAS 34562-31-7 The Secret to Light Yellow Liquid Appearance

In the competitive world of chemical manufacturing, maintaining consistency and meeting precise specifications are essential for success. One compound that highlights these principles is 3,5-Diethyl-1,2-dihydro-1-phenyl-2-propylpyridine, commonly known as PDHP, with the CAS number 34562-31-7. PDHP is a versatile compound utilized in various industrial applications, including rubber additives and catalytic processes. Among its many attributes, Watson’s ability to consistently produce PDHP as a light yellow liquid stands out, especially in industries where the appearance of the final product is crucial. PDHP serves a vital role in several industrial sectors. In the rubber industry, it functions as an additive that enhances the durability and longevity of rubber products. PDHP’s properties help improve the stability of rubber, making it more resistant to environmental wear and tear. Additionally, in catalysis, PDHP’s structure allows it to act as an effective ligand or catalyst precurso...
Post a Comment
Read more

The World's Largest Producer of Squaric Acid Emerges: Watson Leads the Way

In a groundbreaking development for the chemical industry, Watson has officially claimed the title of the world’s largest producer of squaric acid. This achievement marks a significant milestone, positioning the company as a global leader in the production of this highly versatile compound, widely valued in pharmaceuticals, polymer research, and advanced materials. What is Squaric Acid? Squaric acid, also known as quadratic acid, is a four-carbon cyclic diketone with two ketone groups and two hydroxyl groups arranged symmetrically. It is renowned for its stability and strong acidity, making it a unique compound in both organic and inorganic chemistry. Its derivatives find applications in creating advanced coatings, conductive polymers, and as intermediates in drug synthesis. Watson: Redefining Excellence in Squaric Acid Production Watson’s rise to the top of the squaric acid industry is backed by its unmatched production capacity, cutting-edge technology, and unwavering commitment...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product Namemethylammonium iodideIUPAC Namemethylazanium;iodide Molecular StructureCAS Registry Number 14965-49-2MDL NumberMFCD28100833SynonymsMethylammonium iodide14965-49-2methylazanium;iodideEINECS 239-037-4methylazanium iodideMethanamine, hydriodideMethyl ammonium iodideMethylamine.hydriodicacidSCHEMBL1534750Methylammonium Iodide, anhydrousDB-221235NS00086090Molecular FormulaCH6INMolecular Weight158.97InChIInChI=1S/CH5N.HI/c1-2;/h2H2,1H3;1HInChI KeyLLWRXQXPJMPHLR-UHFFFAOYSA-N  Canonical SMILESC. Patent InformationPatent IDTitlePublication DateWO2023/180219A METHOD FOR SYNTHESIS OF HALIDE SALTS2023CN113845428Preparation method of perovskite material powder2021WO2018/169373METHOD OF PREPARING LUMINESCENT NANO-SHEET, LUMINESCENT NANO-SHEET MATERIAL, LUMINESCENT NANO-SHEET FILM, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY APPARATUS2018WO2015/32748AMORPHOUS MATERIAL AND THE USE THEREOF2018 ...
Post a Comment
Read more